PUR.WA
Price:
$4.162
Market Cap:
$33.30M
Pure Biologics Spólka Akcyjna, a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare diseases. It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules. The company offers PureApta, a modular platform for in vitro selection of modified aptamers for therapeutic and diagnostic use. It also engages in the development of non-systemic therapies for use in treating patients suffering from neurolo...[Read more]
Industry
Biotechnology
IPO Date
2018-12-01
Stock Exchange
WSE
Ticker
PUR.WA
According to Pure Biologics Spólka Akcyjna’s latest financial reports and current stock price. The company's current PE Ratio is -2.26. This represents a change of -76.55% compared to the average of -9.64 of the last 4 quarters.
The mean historical PE Ratio of Pure Biologics Spólka Akcyjna over the last ten years is -15.53. The current -2.26 PE Ratio has changed 1.36% with respect to the historical average. Over the past ten years (40 quarters), PUR.WA's PE Ratio was at its highest in in the September 2017 quarter at 15.37. The PE Ratio was at its lowest in in the December 2021 quarter at -63.26.
Average
-15.53
Median
-13.22
Minimum
-34.53
Maximum
-1.13
Discovering the peaks and valleys of Pure Biologics Spólka Akcyjna PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 302.40%
Maximum Annual PE Ratio = -1.13
Minimum Annual Increase = -85.35%
Minimum Annual PE Ratio = -34.53
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -4.54 | 302.40% |
| 2023 | -1.13 | -41.69% |
| 2022 | -1.94 | -85.35% |
| 2021 | -13.22 | -13.22% |
| 2020 | -15.24 | 37.86% |
| 2019 | -11.05 | -67.99% |
| 2018 | -34.53 | 16.02% |
| 2017 | -29.76 | 4.89% |
The current PE Ratio of Pure Biologics Spólka Akcyjna (PUR.WA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.54
5-year avg
-7.21
10-year avg
-15.53
Pure Biologics Spólka Akcyjna’s PE Ratio is greater than Urteste S.A. (-12.44), greater than Pharmena S.A. (-17.12), less than Airway Medix S.A. (19.28), less than BioMaxima S.A. (68.99), greater than NanoGroup S.A. (-12.86), greater than Genomtec S.A. (-5.56), greater than Poltreg S.A. (-4.57), greater than Mabion S.A. (-3.35), less than Adiuvo Investments S.A. (6.32), greater than Molecure S.A. (-4.97),
| Company | PE Ratio | Market cap |
|---|---|---|
| -12.44 | $51.73M | |
| -17.12 | $33.97M | |
| 19.28 | $36.35M | |
| 68.99 | $48.43M | |
| -12.86 | $90.06M | |
| -5.56 | $66.21M | |
| -4.57 | $111.46M | |
| -3.35 | $130.43M | |
| 6.32 | $8.56M | |
| -4.97 | $150.20M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pure Biologics Spólka Akcyjna using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pure Biologics Spólka Akcyjna or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Pure Biologics Spólka Akcyjna's PE Ratio?
How is the PE Ratio calculated for Pure Biologics Spólka Akcyjna (PUR.WA)?
What is the highest PE Ratio for Pure Biologics Spólka Akcyjna (PUR.WA)?
What is the 3-year average PE Ratio for Pure Biologics Spólka Akcyjna (PUR.WA)?
What is the 5-year average PE Ratio for Pure Biologics Spólka Akcyjna (PUR.WA)?
How does the current PE Ratio for Pure Biologics Spólka Akcyjna (PUR.WA) compare to its historical average?